Please allow me to introduce myself

[Jackpine Radical]

44. Bio from Wikipedia:

He worked for the FDA before he worked for Monsanto; now back @ FDA. Revolving door guy. Pro-GMO, pro carcinogen.

We're so fucked.

He received a B.A. degree in political science from Davidson College and a law degree from the University of Virginia. In 1976, after passing the bar examination, Taylor became a staff attorney for the FDA, where he was executive assistant to the Commissioner.[1][2]
In 1981 he went into private practice at King & Spalding, a law firm, one client of which was the biotechnology company Monsanto,[3] where he established and led the firm's food and drug law practice.[1][2]
In 1988 he published an article entitled "The De Minimis Interpretation of the Delaney Clause: Legal and Policy Rationale "in the Journal of the American College of Toxicology (now called the International Journal of Toxicology), which he had previously presented in December 1986 at a symposium on Topics in Risk Analysis, sponsored by International Life Sciences Institute Risk Science Institute, Society for Risk Analysis, and Brookings Institution.[4] The paper was delivered and published during the midst of a debate and litigation over federal agencies' interpretation of the Delaney clause, a part of federal law written in 1958 that on its face, literally prohibits any chemical from being added, in any amount, to food that is processed, if that agent is carcinogenic. As analytical instrumentation increased in power and more and more agents were found to be carcinogenic at very low levels, the agencies had developed a quantitative risk assessment approach to interpreting the Delaney Clause, which stated that if a carcinogen was present at levels less than 1 in 1,000,000 parts, the risk of that carcinogen was "de minimis" and it could be allowed on the market.[5] In the article, Taylor presented arguments in favor of this approach. Advocates in favor of organic food have criticized Taylor for taking this stance and have attributed the stance not to a good faith effort to reasonably regulate, but to an alleged desire to benefit Monsanto financially.[6]
On July 17, 1991, Michael Taylor left King & Spalding, returning to the FDA to fill the newly created post of Deputy Commissioner for Policy. During that time, he signed the Federal Register notice stating that milk from cows treated with BGH did not have to be labeled as such.[1][7] His name is not on the FDA’s 1992 policy statement on genetically engineered plant foods,[8] but he is said to have been a co-author.[1] Both of these documents grew out of, and fall within, the regulatory policy framework that was developed starting in the mid 1980s under the Reagan and Bush Administrations to ensure safety of the public and to ensure the continuing development of the fledgling biotechnology industry without overly burdensome regulation.[9] The policy had three tenets: &quot 1) U.S. policy would focus on the product of GM techniques, not the process itself, (2) only regulation grounded in verifiable scientific risks would be tolerated, and (3) GM products are on a continuum with existing products and, therefore, existing statutes are sufficient to review the products."[9]